dronabinol has been researched along with semustine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creagan, ET; Frytak, S; Moertel, CG; O'Connell, MJ; O'Fallon, JR; Rubin, J; Schutt, AJ; Schwartau, NW | 1 |
| Carchman, RA; Harris, LS; Munson, AE | 1 |
| Frytak, S; Moertel, CG; Rubin, J | 1 |
1 trial(s) available for dronabinol and semustine
| Article | Year |
|---|---|
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.
Topics: Adult; Aged; Antiemetics; Double-Blind Method; Dronabinol; Drug Evaluation; Fluorouracil; Gastrointestinal Neoplasms; Humans; Middle Aged; Nausea; Nitrosourea Compounds; Placebos; Prochlorperazine; Semustine; Vomiting | 1979 |
2 other study(ies) available for dronabinol and semustine
| Article | Year |
|---|---|
The inhibition of DNA synthesis by cannabinoids.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cannabidiol; Cannabis; Cyclophosphamide; Cytarabine; DNA; DNA, Neoplasm; Dronabinol; Fluorouracil; Idoxuridine; Leukemia L1210; Lung Neoplasms; Mice; Neoplasms, Experimental; Semustine | 1976 |
Metabolic studies of delta-9-tetrahydrocannabinol in cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dronabinol; Female; Fluorouracil; Gastrointestinal Neoplasms; Half-Life; Humans; Kinetics; Liver Neoplasms; Male; Middle Aged; Semustine | 1984 |